OncoK9 Cancer SAFE Tool Disclosures | PetDx®

OncoK9® Cancer SAFE Tool Disclosures

The OncoK9® Cancer SAFE™ (Screening Age For Early detection) Tool is intended for use in adult dogs one year of age and older. This tool is meant to assist in determining an appropriate age to start cancer screening in a dog without clinical signs of cancer (i.e., not currently suspected of having cancer). The decision to pursue screening for cancer is a personal one and should be made in consultation with a veterinarian.[nh1] [JC2]  You may choose to start cancer screening prior to the recommended age, at your discretion and in consultation with your veterinarian. PetDx does not assume any responsibility for any actions taken based on the recommendations provided by this tool. Use of the OncoK9 Cancer SAFE tool is for educational purposes only[nh3] [JC4] ; any information derived from using the tool should not be considered as a guarantee of any particular health risk or clinical outcome for your dog. PetDx does not assume any liability for recommendations or outcomes related to use of the OncoK9 Cancer SAFE tool.

The OncoK9 Cancer SAFE Tool is not intended to be used for dogs in which cancer is currently suspected, including but not limited to dogs with: abnormal or rapidly growing masses, sores that do not heal, loss of appetite/unexplained weight loss, bleeding/discharge, difficulty eating/swallowing/breathing, lameness, or difficulty urinating/defecating[nh5] [JC6] [AF7] .8 If your dog is exhibiting any of these clinical signs, please consult your veterinarian.

The OncoK9 Cancer SAFE tool was developed using a large cohort of dogs representing a wide range of breeds and cancer types.1 However, certain limitations must be acknowledged.

For the list of pure breeds available for selection in the tool, the recommended screening age was derived from a cohort of at least 10 cancer-diagnosed subjects belonging to each breed.[nh8] [JC9] [AF10] 

With regard to the geographical distribution of subjects, it is estimated that over 95% of dogs in this study were from the United States. This factor may limit the generalizability of the study findings to other countries where different environmental characteristics, spay-neuter practices, breed distributions, or other considerations may play a role in cancer development.

Further limitations of the clinical study that provided the scientific foundation for this tool can be found at: https://doi.org/10.1101/2022.03.30.486448

To review OncoK9 test limitations and risks, please visit: oncok9.info/limitations.

Top